NCT06525038

Brief Summary

Frailty scores can predict hospitalization and other related adversities. Thus, the frailty status determination is useful in clinical decisions regarding elderly patients. This study aimed to evaluate the potential of PRISMA-7 and SARC-F scores in predicting hospitalization following emergency department (ED) admission, readmission at 1, 3, and 6 months, and mortality within a 6-month follow-up period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
Last Updated

July 29, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

July 19, 2024

Last Update Submit

July 24, 2024

Conditions

Keywords

Emergency ServiceMortalitySarcopeniaFrailty

Outcome Measures

Primary Outcomes (2)

  • Mortality

    up to 6 months

  • Readmission to the Emergency Department

    up to 6 months

Study Arms (4)

Risk of sarcopenia (-) and risk of frailty (-)

Other: All groups were observed for clinical end-points described in the study protocol

Risk of sarcopenia (+) and risk of frailty (-)

Other: All groups were observed for clinical end-points described in the study protocol

Risk of sarcopenia (-) and risk of frailty (+)

Other: All groups were observed for clinical end-points described in the study protocol

Risk of sarcopenia (+) and risk of frailty (+)

Other: All groups were observed for clinical end-points described in the study protocol

Interventions

All groups were observed for clinical end-points (mortality, readmission to emergency service) described in the study protocol.

Risk of sarcopenia (+) and risk of frailty (+)Risk of sarcopenia (+) and risk of frailty (-)Risk of sarcopenia (-) and risk of frailty (+)Risk of sarcopenia (-) and risk of frailty (-)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged over 65 years and admitted to the emergency department

You may qualify if:

  • Patients aged over 65 years

You may not qualify if:

  • Patients with no spontaneous heartbeat or breathing at the time of ED arrival

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Firat University School of Medicine

Elâzığ, 23119, Turkey (Türkiye)

Location

MeSH Terms

Conditions

FrailtySarcopenia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

July 19, 2024

First Posted

July 29, 2024

Study Start

January 1, 2023

Primary Completion

July 31, 2023

Study Completion

September 30, 2023

Last Updated

July 29, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

The data will be available to the researchers, and they will be shared if wanted.

Locations